Eléments de l'association
|
List of bibliographic references
Number of relevant bibliographic references: 9.Ident. | Authors (with country if any) | Title |
---|---|---|
002A05 | A. Frazier-Mironer [France] ; A. Cantagrel [France] ; B. Combe [France] ; V. Deschamps ; M. Dougados [France] ; R.-M. Flipo ; I. Logeart ; X. Mariette ; T. Schaeverbeke ; J. Sibilia [France] ; X. Le Loët [France] | THU0173 Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biologic Therapy in Patients with Rheumatoid Arthritis in Daily Practice: The Maintain Study |
002B72 | A. Saraux ; S. Rouanet ; R.-M. Flipo ; J.-C. Poncet ; P. Fardellone ; C. Contré [France] ; A. Cantagrel [France] | SAT0111 Description of Glucocorticoid Sparing Effect in Rheumatoid Arthritis (RA) Patients Treated by Tocilizumab (TCZ) in Real Life: An Interim Analysis of the Spare-1 Study |
002B74 | G. R. Burmester [Allemagne] ; A. Rubbert-Roth [Allemagne] ; A. Cantagrel [France] ; S. Hall [Australie] ; P. Leszczynski [Pologne] ; D. Feldman [Brésil] ; M. J. Rangaraj ; G. Roane ; C. Ludivico [États-Unis] ; E. Mysler [Argentine] ; L. Rowell [Royaume-Uni] ; I. Vranic [Royaume-Uni] | SAT0105 Summacta: A Randomized, Double-Blind, Parallel Group Study of the Safety and Efficacy Of Tocilizumab SC Versus Tocilizumab IV, in Combination with Traditional Dmards in Patients With Moderate to Severe Ra |
002C08 | T. Krams ; A. Ruyssen-Wtrand [France] ; D. Nigon ; B. Fautrel ; F. Berenbaum [France] ; A. Cantagrel ; A. Constantin [France] | SAT0022 In Rheumatoid Arthritis, Younger Age at Onset is Associated with a Higher Rate of Remission at 1 Year: Results from a French Cohort of Early Arthritis Patients (Espoir Cohort) |
002C92 | R. Seror ; S. Legall ; M. Bonnaure-Mallet ; T. Schaeverbeke ; A. Cantagrel [France] ; X. Mariette | OP0186 Analysis of Anti Porphyromonas Gingivalis (PG) Antibodies in a Large Cohort of Patients with an Early Arthritis (ESPOIR) |
002D23 | A. Ruyssen-Witrand [France] ; P.-A. Gourraud [États-Unis] ; D. Nigon [France] ; C. Lukas [France] ; C. Miceli-Richard ; B. Jamard ; A. Cantagrel ; A. Cambon-Thomsen [France] ; P. Dieudé [France] ; A. Constantin [France] | OP0050 Evolution of the alternative classification of HLA-DRB1 alleles in rheumatoid arthritis: Impact on the production of the anti-citrullinated protein antibodies and structural progression, data from the ESPOIR cohort |
002E04 | J. Morel [France] ; M. O. Duzanski [France] ; A. Cantagrel [France] ; B. Combe [France] ; M. Dougados [France] ; R. M. Flipo ; J. E. Gottenberg [France] ; X. Mariette [France] ; O. Vittecoq ; A. Saraux ; T. Schaeverbeke ; T. Bardin [France] ; M. Soubrier ; P. Ravaud [France] ; J. Siblia [France] | FRI0245 Prospective follow-up of tocilizumab treatment in 1100 patients with refractory rheumatoid arthritis: tolerance data from the french registry regate (registry –roactemra) |
003560 | J E Gottenberg [France] ; P. Ravaud [France] ; A. Cantagrel [France] ; B. Combe [France] ; R M Flipo [France] ; T. Schaeverbeke [France] ; E. Houvenagel [France] ; P. Gaudin [France] ; D. Loeuille [France] ; S. Rist [France] ; M. Dougados [France] ; J. Sibilia [France] ; X. Le Loët [France] ; C. Marcelli [France] ; T. Bardin [France] ; I. Pane [France] ; G. Baron [France] ; X. Mariette [France] | Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry |
004097 | P. Emery [Royaume-Uni] ; E. Keystone [Canada] ; H P Tony [Allemagne] ; A. Cantagrel [France] ; R. Van Vollenhoven [Suède] ; A. Sanchez [Mexique] ; E. Alecock [Royaume-Uni] ; J. Lee [États-Unis] ; J. Kremer [États-Unis] | IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial |
This area was generated with Dilib version V0.6.34. |